James A. Dowell

Once-Weekly Dalbavancin versus Standard-of-Care Antimicrobial Regimens for Treatment of Skin and Soft-Tissue Infections

Elyse Seltzer, MaryBeth Dorr, Beth P. Goldstein et al. · Clinical Infectious Diseases · 2003 · 233 citations

Safety and Pharmacokinetics of Intravenous Anidulafungin in Children with Neutropenia at High Risk for Invasive Fungal Infections

Daniel K. Benjamin, Timothy Driscoll, Nita L. Seibel et al. · Antimicrobial Agents and Chemotherapy · 2006 · 211 citations · Full text

Antifungal Agent, Antifungal Agents, Pharmacology +12

Population Pharmacokinetic Analysis of Anidulafungin, an Echinocandin Antifungal

James A. Dowell, William Knebel, Tom Ludden et al. · The Journal of Clinical Pharmacology · 2004 · 168 citations

Serious Fungal Disease, Analysis Population, Antifungal Agent +8

Stoichiometry of Site-specific Lysine Acetylation in an Entire Proteome

Josue Baeza, James A. Dowell, Michael J. Smallegan et al. · Journal of Biological Chemistry · 2014 · 155 citations · Full text

Pharmacokinetics of Gemtuzumab Ozogamicin, an Antibody‐Targeted Chemotherapy Agent for the Treatment of Patients with Acute Myeloid Leukemia in First Relapse

James A. Dowell, Joan Korth‐Bradley, Hanjiu Liu et al. · The Journal of Clinical Pharmacology · 2001 · 152 citations